With over three decades of experience in regulatory affairs, clinical research, and pharmacovigilance, this accomplished professional currently serves as a Medical and Regulatory Affairs Expert for ProRelix Research. In this capacity, she plays a pivotal role in ensuring compliance with national and international regulatory standards, overseeing clinical trials, and safeguarding patient safety.

For ProRelix Research, she is instrumental in guiding regulatory strategies and ensuring adherence to global compliance standards. Her expertise in medical affairs ensures that our clinical trials are designed with the highest ethical standards, prioritizing patient safety and data integrity, thereby enhancing the efficiency and success of clinical development programs.

Her career trajectory is marked by significant contributions to India’s regulatory landscape. She holds esteemed positions at the Indian Pharmacopoeia Commission (IPC) as a Medical Expert contributing to the development and revision of monographs and standards to ensure the quality and safety of pharmaceutical practices in India. Prior to her current role, she served as a Medical Consultant at the Central Drugs Standard Control Organization (CDSCO), Chief Operating Officer (COO) at Fortis Clinical Research Ltd., and Senior Vice President – Medical Affairs, Clinical Research, and Regulatory Affairs at LG Life Sciences.

Her extensive experience has a profound impact on ProRelix Research. Her deep understanding of regulatory frameworks and clinical operations ensures compliance and patient safety. Her leadership in medical and regulatory affairs fosters a culture of excellence, delivering high-quality clinical development services. Through her guidance, ProRelix Research continues to build strong relationships with regulatory bodies and stakeholders, reinforcing its reputation as a trusted partner in the global pharmaceutical industry.